| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |